openPR Logo
Press release

Cushing's Syndrome Market Forecast: Segments, Drivers, and Growth Factors to 2031 - Corcept Therapeutics, Piramal Pharma Solutions, LGM Pharma.

10-15-2024 07:20 AM CET | Health & Medicine

Press release from: DataM Intelligence 4market Research LLP

Cushing's Syndrome Market

Cushing's Syndrome Market

DataM Intelligence has released a new research report on the Cushing's Syndrome market. The report provides a detailed analysis of current and emerging trends, offering insights into the market dynamics. It utilizes Porter's Five Forces model to assess key factors such as supplier and customer relationships, risks from various agents, competitive intensity, and opportunities for new entrants. The study also includes research data from various companies, analyzing factors like benefits, gross margins, and strategic decisions in the global market. The report is enriched with tables, charts, and infographics for a clear presentation of the findings.

Global Cushing's syndrome market reached US$ 146.5 million in 2023 and is expected to reach US$ 291.1 million by 2031 growing with a CAGR of 8.96% during the forecast period 2024-2031.

Get a Free Sample Research PDF - https://datamintelligence.com/download-sample/cushing's-syndrome-market

Cushing's syndrome is a hormonal disorder caused by prolonged exposure to high levels of cortisol, often due to overuse of corticosteroid medications or a tumor in the adrenal or pituitary glands. Symptoms include weight gain, particularly in the face, neck, and abdomen, thinning skin, easy bruising, and muscle weakness. It can also lead to high blood pressure, osteoporosis, and diabetes. Diagnosis typically involves blood, urine, and saliva tests to measure cortisol levels, along with imaging studies to locate tumors. Treatment depends on the cause and may include surgery, radiation, or medication.

List of the Key Players in the Cushing's Syndrome Market:

Corcept Therapeutics, Piramal Pharma Solutions, LGM Pharma, Sigma Aldrich, Tocris Bioscience, Tecoland Corporation, Sparrow Pharmaceuticals, Novartis AG, Xeris Biopharma, and Zhejiang Supor Pharmaceuticals Co. Ltd.

Key Developments:

In February 2023, Bristol Practice introduced a groundbreaking 3D printing guide to assist in surgeries for Cushing's disease. The innovative system was developed with financial support from a research program sponsored by CVS Group. This guide aims to enhance surgical precision in removing tumors that cause Cushing's disease, improving patient outcomes. The use of 3D printing technology provides a tailored approach to surgery, helping surgeons better visualize and navigate complex anatomical structures. This advancement represents a significant step forward in personalized medical care for patients with Cushing's disease.

Research Process:

Both primary and secondary data sources have been used in the global Cushing's Syndrome Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

Segment Covered in the Cushing's Syndrome Market:

By Type: Exogenous Cushing's Syndrome, Endogenous Cushing's Syndrome

By Treatment: Medications, Surgery, Radiation Therapy, Chemotherapy , Others

By End Users: Hospitals, Specialty Clinics, Others

Get Customization in the report as per your requirements: https://datamintelligence.com/customize/cushing's-syndrome-market

Regional Analysis:

➣ North America (US, Canada, Mexico)

➣ Europe (Germany, Russia, UK, France, Italy, Spain, Rest of Europe)

➣ Asia-Pacific (China, India, Japan, Australia, Rest of Asia Pacific)

➣ South America (Brazil, Argentina, Rest of South America)

➣ Middle East and Africa

**The full version of the report includes an in-depth analysis of emerging players and startups, which will provide valuable insights into the evolving market landscape and key strategies being adopted**

Chapter Outline:

⏩ Market Overview: It contains five chapters, as well as information about the research scope, major manufacturers covered, market segments, Cushing's Syndrome market segments, study objectives, and years considered.

⏩ Market Landscape: The competition in the Global Cushing's Syndrome Market is evaluated here in terms of value, turnover, revenues, and market share by organization, as well as market rate, competitive landscape, and recent developments, transaction, growth, sale, and market shares of top companies.

⏩ Companies Profiles: The global Cushing's Syndrome market's leading players are studied based on sales, main products, gross profit margin, revenue, price, and growth production.

⏩ Market Outlook by Region: The report goes through gross margin, sales, income, supply, market share, CAGR, and market size by region in this segment. North America, Europe, Asia Pacific, Middle East & Africa, and South America are among the regions and countries studied in depth in this study.

⏩ Market Segments: It contains the deep research study which interprets how different end-user/application/type segments contribute to the Cushing's Syndrome Market.

⏩ Market Forecast: Production Side: In this part of the report, the authors have focused on production and production value forecast, key producers forecast, and production and production value forecast by type.

⏩ Research Findings: This section of the report showcases the findings and analysis of the report.

⏩ Conclusion: This portion of the report is the last section of the report where the conclusion of the research study is provided.

Have any Query? Talk to our Expert @ https://www.datamintelligence.com/enquiry/cushing's-syndrome-market

The Research Report Offers Answers To The Following Questions:

☛ What is the expected growth rate of the global market for the forecast period?

☛ What are the key driving factors that are responsible to shape the fate of the Cushing's Syndrome market during the forecast period?

☛ What will be the overall size of the market during the analysis period?

☛ What are the prominent market trends which influence the development of the Cushing's Syndrome market across various regions?

☛ Who are the key market players and the market strategies that have helped them to secure the leading position in the global market?

☛ What are the challenges and threats that are likely to act as a barrier to the growth of the Cushing's Syndrome market?

☛ What are the major opportunities that the companies can get to attain success in the world?

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Cushing's Syndrome Market Forecast: Segments, Drivers, and Growth Factors to 2031 - Corcept Therapeutics, Piramal Pharma Solutions, LGM Pharma. here

News-ID: 3692365 • Views:

More Releases from DataM Intelligence 4market Research LLP

Plant-Based Probiotics Market to Reach USD 1,382.3 Million by 2031 at 6.1% CAGR, Fueled by Gut Health Awareness, Dairy-Free Lifestyles, and Key Players Including Danone, Nestlé, Yakult, Probi AB, and Renew Life
Plant-Based Probiotics Market to Reach USD 1,382.3 Million by 2031 at 6.1% CAGR, …
The Nutritional Yeast Market reached US$ 341.22 million in 2024 and is expected to grow to around US$ 623.66 million by 2032, expanding with a CAGR of approximately 7.83 % from 2025 to 2032 as consumer preferences shift toward plant‐based and nutrient‐rich foods. Growth is supported by increasing demand across key applications such as food & beverages, animal feed & pet food, and other functional nutrition segments, driven by rising interest
Transcranial Direct Current Stimulation Market to Reach USD 2.74 Billion by 2031, Driven by Neuromodulation Adoption and Home-Based Therapy Solutions | Top Companies are Soterix Medical Inc., TheBrainDriver, LLC., Neurocare group AG
Transcranial Direct Current Stimulation Market to Reach USD 2.74 Billion by 2031 …
The Global Transcranial Direct Current Stimulation Market reached US$ 1,346.13 million in 2023 and is expected to reach US$ 2,741.88 million by 2031 growing with a CAGR of 9.3% during the forecast period 2024-2031. The Transcranial Direct Current Stimulation Market report by DataM Intelligence provides comprehensive insights and analysis on key market trends, growth opportunities, and emerging challenges. With a commitment to delivering actionable intelligence, DataM Intelligence empowers businesses to make
Nutritional Yeast Market to Reach USD 623.66 Million by 2032 at 7.83% CAGR, Driven by Plant-Based Diets, Functional Foods, and Key Players Including Red Star, Lesaffre, Angel Yeast, DSM, and MGP Ingredients
Nutritional Yeast Market to Reach USD 623.66 Million by 2032 at 7.83% CAGR, Driv …
The Nutritional Yeast Market reached US$ 341.22 million in 2024 and is expected to grow to around US$ 623.66 million by 2032, expanding with a CAGR of approximately 7.83 % from 2025 to 2032 as consumer preferences shift toward plant‐based and nutrient‐rich foods. Growth is supported by increasing demand across key applications such as food & beverages, dietary supplements, animal feed & pet food, and other functional nutrition segments, driven by
Cloud Native Platforms Market to Reach USD 27.4 Billion by 2031, Driven by AI Integration, Hybrid Cloud Adoption, and Digital Transformation Initiatives | Top Companies are Infosys Corp., Bacancy technology Pvt ltd., Pivotal infrastructure Pvt ltd
Cloud Native Platforms Market to Reach USD 27.4 Billion by 2031, Driven by AI In …
The Global Cloud Native Platforms Market reached US$ 4.9 billion in 2023 and is expected to reach US$ 27.4 billion by 2031, growing with a CAGR of 24.1% during the forecast period 2024-2031. DataM Intelligence has published a new research report on "Cloud Native Platforms Market Size 2024". The report explores comprehensive and insightful Information about various key factors like Regional Growth, Segmentation, CAGR, Business Revenue Status of Top Key Players

All 5 Releases


More Releases for Cushing

Terence Cushing Launches Personal Pledge for Proactive Legal Readiness
Image: https://www.globalnewslines.com/uploads/2026/01/1768402291.jpg Terence Cushing, Phoenix, AZ, USA. Terence Cushing of Phoenix, Arizona outlines a personal commitment to prevention, clarity, and responsible decision-making in today's complex legal environment. Terence "Terry" Cushing, Senior Corporate Counsel and veteran litigation attorney, has announced the launch of a new personal pledge focused on proactive legal readiness, clear communication, and early risk awareness. The pledge reflects lessons drawn from nearly two decades in federal courts, private practice, and corporate
Cushing Syndrome Clinical Trial Pipeline Shows Potential with Active Contributio …
DelveInsight's "Cushing Syndrome Pipeline Insight 2026" report provides comprehensive insights about 4+ companies and 4+ pipeline drugs in the Cushing Syndrome pipeline landscape. It covers the Cushing Syndrome Pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Cushing Syndrome Pipeline Therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Curious about the latest updates
Cushing Syndrome Market Is Going to Boom | Major Giants HRA Pharma • Recordati …
Coherent Market Insights has released a report titled "Cushing Syndrome Market: Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2025-2032", which includes market percentage records and a thorough enterprise analysis. This report looks at the market's competition, geographic distribution, and growth potential. This comprehensive report encompasses industry performance, critical success factors, risk assessment, manufacturing prerequisites, project expenses, economic analysis, anticipated return on investment (ROI), and profit margins. ➤ Christmas Exclusive Deal
Cushing Syndrome Market Trends is Electrifying Growth Cycle: Bristol Myers Squib …
The latest study released on the Global Cushing Syndrome Market by HTF MI Research evaluates market size, trend, and forecast to 2031. The Cushing Syndrome market study covers significant research data and proofs to be a handy resource document for managers, analysts, industry experts and other key people to have ready-to-access and self-analysed study to help understand market trends, growth drivers, opportunities and upcoming challenges and about the competitors. Key Players
Cushing Syndrome Pipeline Appears Robust With 4+ Key Pharma Companies Actively W …
DelveInsight's, "Cushing Syndrome Pipeline Insight, 2025" report provides comprehensive insights about 4+ companies and 4+ pipeline drugs in Cushing Syndrome pipeline landscape. It covers the Cushing Syndrome pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Cushing Syndrome therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Explore our latest breakthroughs in Cushing Syndrome
Cushing Syndrome Market Is Booming So Rapidly | Recordati, Diurnal Group, Pfizer
The Global Cushing Syndrome Market Size is estimated at $1.4 Billion in 2025 and is forecast to register an annual growth rate (CAGR) of 22.6% to reach $8.8 Billion by 2034. The latest study released on the Global Cushing Syndrome Market by USD Analytics Market evaluates market size, trend, and forecast to 2034. The Cushing Syndrome market study covers significant research data and proofs to be a handy resource document for